Belite Bio, Inc

This study tests a drug called tinlarebant in 60 people with Stargardt disease, a genetic condition that causes vision loss. The goal is to see if the drug can slow the growth of damage in the back of the eye and help preserve sight. Participants will receive either the drug or a…

This study tests an experimental drug called tinlarebant in 429 adults with geographic atrophy, an advanced form of dry age-related macular degeneration that causes blind spots. The goal is to see if the drug can slow the growth of damaged areas in the eye and preserve vision. Pa…